Cellectar Biosciences Inc (CLRB)
3.335
+0.18
(+5.54%)
USD |
NASDAQ |
May 02, 16:00
3.335
0.00 (0.00%)
After-Hours: 19:44
Cellectar Biosciences 1 Year Total Returns (Daily): 100.0% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 01, 2024 | 100.0% |
| April 30, 2024 | 100.6% |
| April 29, 2024 | 101.3% |
| April 26, 2024 | 107.4% |
| April 25, 2024 | 104.1% |
| April 24, 2024 | 112.5% |
| April 23, 2024 | 110.1% |
| April 22, 2024 | 115.5% |
| April 19, 2024 | 96.12% |
| April 18, 2024 | 92.41% |
| April 17, 2024 | 103.2% |
| April 16, 2024 | 136.4% |
| April 15, 2024 | 137.1% |
| April 12, 2024 | 152.5% |
| April 11, 2024 | 168.8% |
| April 10, 2024 | 154.7% |
| April 09, 2024 | 168.3% |
| April 08, 2024 | 174.1% |
| April 05, 2024 | 178.5% |
| April 04, 2024 | 163.8% |
| April 03, 2024 | 172.6% |
| April 02, 2024 | 179.0% |
| April 01, 2024 | 174.1% |
| March 28, 2024 | 180.3% |
| March 27, 2024 | 142.3% |
| Date | Value |
|---|---|
| March 26, 2024 | 155.0% |
| March 25, 2024 | 156.3% |
| March 22, 2024 | 169.1% |
| March 21, 2024 | 152.9% |
| March 20, 2024 | 147.0% |
| March 19, 2024 | 148.7% |
| March 18, 2024 | 120.4% |
| March 15, 2024 | 128.9% |
| March 14, 2024 | 113.9% |
| March 13, 2024 | 126.9% |
| March 12, 2024 | 125.5% |
| March 11, 2024 | 134.2% |
| March 08, 2024 | 110.5% |
| March 07, 2024 | 107.7% |
| March 06, 2024 | 110.5% |
| March 05, 2024 | 115.4% |
| March 04, 2024 | 125.5% |
| March 01, 2024 | 154.5% |
| February 29, 2024 | 151.3% |
| February 28, 2024 | 152.6% |
| February 27, 2024 | 158.7% |
| February 26, 2024 | 123.7% |
| February 23, 2024 | 111.4% |
| February 22, 2024 | 120.4% |
| February 21, 2024 | 106.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.40%
Minimum
May 20 2019
180.3%
Maximum
Mar 28 2024
-25.48%
Average
-36.70%
Median
Aug 18 2020
1 Year Total Returns (Daily) Benchmarks
| Perspective Therapeutics Inc | 176.8% |
| Eli Lilly and Co | 92.99% |
| Actinium Pharmaceuticals Inc | -14.97% |
| Bristol-Myers Squibb Co | -32.59% |
| Altimmune Inc | 43.70% |